Accueil / Tag Archives: Washington (page 5)

Tag Archives: Washington

Seattle Genetics Announces Publication of North American Subgroup Data from ECHELON-1 Phase 3 Clinical Trial of ADCETRIS® (Brentuximab Vedotin) in Newly Diagnosed Advanced Hodgkin Lymphoma

Wednesday, January 9th 2019 at 1:00pm UTC -North American Subgroup Analysis Trial Results Published in Clinical Cancer Research- -Data Consistent with ECHELON-1 Trial Outcome Showing Superior Clinical Activity of ADCETRIS in Combination with AVD when Compared to ABVD in Frontline Advanced Hodgkin Lymphoma- BOTHELL, Wash.–(BUSINESS WIRE)– Seattle Genetics, Inc. (Nasdaq:SGEN) …

Plus »

Adaptive Biotechnologies to Present at the 37th Annual J.P. Morgan Healthcare Conference

Thursday, January 3rd 2019 at 12:00pm UTC SEATTLE–(BUSINESS WIRE)– Adaptive Biotechnologies today announced that Chad Robins, chief executive officer and co-founder, will present at the 37th Annual J.P. Morgan Healthcare Conference on January 8, 2019 at 11:30 am PT (2:30 pm ET) in San Francisco. Robins will also participate in …

Plus »

Seattle Genetics to Present at the J.P. Morgan Healthcare Conference

Wednesday, December 19th 2018 at 1:00pm UTC BOTHELL, Wash.–(BUSINESS WIRE)– Seattle Genetics, Inc. (NASDAQ:SGEN) announced today that management will present at the 37th Annual J.P. Morgan Healthcare Conference on Monday, January 7, 2019 at 2:30 p.m. Pacific Time. Both the presentation and question and answer session that follows at 3:00 …

Plus »

Juno Therapeutics Prices $250 Million Follow-on Offering

Friday, September 22nd 2017 at 1:13am UTC SEATTLE–(BUSINESS WIRE)– Juno Therapeutics, Inc. (NASDAQ:JUNO), a biopharmaceutical company developing innovative cellular immunotherapies for the treatment of cancer, today announced the pricing of its follow-on public offering of 6,100,000 shares of its common stock at a price to the public of $41.00 per …

Plus »

Juno Therapeutics Launches Follow-on Offering

Wednesday, September 20th 2017 at 8:17pm UTC SEATTLE–(BUSINESS WIRE)– Juno Therapeutics, Inc. (NASDAQ:JUNO), a biopharmaceutical company developing innovative cellular immunotherapies for the treatment of cancer, today announced the launch of a proposed follow-on public offering of $225 million of shares of its common stock. In addition, Juno expects to grant …

Plus »

Juno Therapeutics Opens New Headquarters and Research Center

Thursday, September 21st 2017 at 8:05pm UTC Opening celebration and ribbon-cutting highlight advancements in cell therapy and Juno’s investment in scientific advancement SEATTLE–(BUSINESS WIRE)– Juno Therapeutics, Inc. (NASDAQ: JUNO), a biopharmaceutical company developing innovative cellular immunotherapies for the treatment of cancer, today unveiled its new headquarters and research facility, located in …

Plus »

Nativis to Present at the Ladenburg Thalmann 2017 Healthcare Conference

Wednesday, September 20th 2017 at 12:00pm UTC Updates to include partnerships, clinical program progress and plans for 2018 SEATTLE–(BUSINESS WIRE)– Nativis, Inc., a clinical stage life science bio-electronics company developing non-invasive, safe and highly effective treatments for cancers and other serious diseases, today announced that Chris E. Rivera, Nativis Chief …

Plus »

Alpine Immune Sciences Announces Poster Presentation at 2017 ACR/ARHP Annual Meeting

Wednesday, September 20th 2017 at 12:00pm UTC SEATTLE–(BUSINESS WIRE)– Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading immunotherapy company focused on developing treatments for autoimmune/inflammatory diseases and cancer, today announced a planned poster presentation highlighting recent data from a preclinical study evaluating dual ICOS/CD28 antagonists generated by the Company’s vlgD™ platform …

Plus »

Alpine Immune Sciences to Present at Ladenburg Thalmann 2017 Healthcare Conference

Wednesday, September 13th 2017 at 8:05pm UTC SEATTLE–(BUSINESS WIRE)– Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading immunotherapy company focused on the development of treatments for autoimmune/inflammatory diseases and cancer, announced today that the company will present at the Ladenburg Thalmann 2017 Healthcare Conference in New York on Tuesday, September 26, …

Plus »
>
Macbook Pro
* Intel Core i7 (3.8GHz, 6MB cache)
* Retina Display (2880 x 1880 px)
* NVIDIA GeForce GT 750M (Iris)
* 802.11ac Wi-Fi and Bluetooth 4.0
* Thunderbolt 2 (up to 20Gb/s)
* Faster All-Flash Storage (X1)
* Long Lasting Battery (9 hours)
BIENVENUE CHEZ BIOTECH FINANCES
Vous appréciez nos informations ?
Recevez nos alertes, nos dernières actualités, suivez-nous, enregistrez-vous gratuitement, rejoignez notre communauté. Merci à vous !
ARE YOU READY? GET IT NOW!
Increase more than 500% of Email Subscribers!
Your Information will never be shared with any third party.
DÉCOUVREZ LA SOLUTION STRATA !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHBzOi8vd3d3LmJpb3RlY2gtZmluYW5jZXMuY29tL3dwLWNvbnRlbnQvdXBsb2Fkcy8yMDE1LzA3L1NhdHJhLTIubXA0IiBmcmFtZWJvcmRlcj0iMCIgYWxsb3dmdWxsc2NyZWVuPjwvaWZyYW1lPg==
Retrouvez nous sur http://stratahealth.com/fr/
Un ensemble de solutions performantes
pour assurer le continuum de vos données.
Biotech Finances
SUIVEZ-NOUS, ENREGISTREZ-VOUS !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cueW91dHViZS5jb20vZW1iZWQvajhsU2NITzJtTTAiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
All rights reserved © Company Name, 2014
Concours Genopole Young Biotech Award
* 100 000 € pour la meilleure Biotech
* Réservé aux biotechs hors santé
* 6 mois d'hébergement gratuit
* Un accompagnement personnalisé
* Etude de marché offerte
* Expertise du projet par EY
* Et nombre d'autres avantages...
S'inscrire au 15H BIOTECH EXPRESS
Chaque jour à 15H recevez gratuitement les news des biotechs, des medtechs,et des fonds spécialisés. Levées ; partenariats ; nominations ; fusacq ; closing ; milestone...
2019 (C) All rights reserved.

En cochant cette case, j’accepte la Politique de confidentialité de ce site et de recevoir des informations de notre part.

S'inscrire au 15H BIOTECH EXPRESS
Chaque jour à 15H recevez gratuitement les news des biotechs, des medtechs,et des fonds spécialisés. Levées ; partenariats ; nominations ; fusacq ; closing ; milestone...
2019 (C) All rights reserved.

En cochant cette case, j’accepte la Politique de confidentialité de ce site et de recevoir des informations de notre part.